Nature and Nurture Come Together to Trigger Diabetes

Nature and Nurture Come Together to Trigger Diabetes

Diabetes February 9, 2015 at 9:03 AM 0 comments

THE EPIGENOME has been revealed to play a significant role in diabetes onset, providing clues into how genes and the environment interact to proliferate this worldwide phenomenon. To investigate the potential role of epigenetics in Type 2 diabetes (T2D) incidence, Dr Andrew Feinberg, Gilman Scholar and Director of the CenterRead More

AbbVie’s VIEKIRAX® (Ombitasvir/Paritaprevir/Ritonavir) and EXVIERA ® (Dasabuvir) Licensed for Use in the UK for the Treatment of Chronic Hepatitis C

Uncategorized February 4, 2015 at 5:32 PM 0 comments

 First treatments for chronic hepatitis C to combine three direct-acting antiviral agents to target hepatitis C virus (HCV) at multiple steps in the viral lifecycle VIEKIRAX® and EXVIERA®, with or without ribavirin (RBV),  cleared the virus in 97 percent of chronic genotype 1 (GT1) HCV patients and was generally wellRead More

New Stats Reveal Almost Half of the UK Are Unaware of Crucial Link between Diet and Cancer Development

Uncategorized February 3, 2015 at 4:27 PM 0 comments

Surprising new statistics reveal that 41% of the British population are oblivious to the role that diet plays in the development of cancer – and even those with a family history of the disease are failing to consume potentially “cancer-preventing” compounds in their daily diet.1 The World Health Organisation suggestsRead More

Targeting Monocytes to Help Treat Autoimmune Disorders?

Targeting Monocytes to Help Treat Autoimmune Disorders?

Rheumatology February 2, 2015 at 9:21 AM 0 comments

SUPPRESSION of the immune system in fighting diseases could be the fault of a population of white blood cells (WBCs), a group of studies led by St Jude Children’s Research Hospital, Memphis, Tennessee, USA, has shown. According to Dr Peter Murray, co-author of one of these studies and a memberRead More

Monitoring ADMA Levels the Key to Avoiding Cardiovascular Disease?

Monitoring ADMA Levels the Key to Avoiding Cardiovascular Disease?

Rheumatology February 2, 2015 at 9:10 AM 0 comments

FEARFUL side-effects that have prohibited the appearance of certain anti-inflammatory arthritis drugs in our pharmacies could soon become irrelevant, after researchers uncover a potential test to identify just who should avoid COX-2 inhibitors. COX-2 inhibitors, a type of non-steroidal anti-inflammatory drug (NSAID), are widely used for providing pain relief toRead More

Quick Imaging Unlocks Path to Valvular Heart Disease Treatment

Quick Imaging Unlocks Path to Valvular Heart Disease Treatment

Cardiology January 26, 2015 at 9:30 AM 0 comments

ACCURACY of the physical diagnoses of heart conditions is boosted through the use of a handheld ultrasound device, with more successful diagnoses of valvular heart disease (VHD) compared to traditional methods. Traditionally identified through the detection of a heart murmur using a stethoscope, VHD may be detected by an echocardiogramRead More

Key to Heart Attack Treatment May Come from Within

Key to Heart Attack Treatment May Come from Within

Cardiology January 26, 2015 at 9:25 AM 0 comments

INTRACORONARY injection of a patient’s own bone marrow (BM) cells could emerge as the ultimate treatment for heart attacks. Selected for their healing potential, a particular group of BM cells – known as endothelial progenitor cells – are believed to trigger healing and blood flow recovery. In the PreSERVE-AMI PhaseRead More

Basilea Announces That FDA’s Anti-Infective Drugs Advisory Committee Recommends Approval of Isavuconazole for the Treatment of Invasive Aspergillosis and Mucormycosis

Uncategorized January 23, 2015 at 2:25 PM 0 comments

Basel, Switzerland, January 22, 2015 – Basilea Pharmaceutica Ltd. (SIX: BSLN) today announced that the U.S. Food and Drug Administration’s (FDA) Anti-Infective Drugs Advisory Committee voted unanimously to recommend approval of the investigational once-daily intravenous and oral antifungal isavuconazole, the active moiety of the prodrug isavuconazonium sulfate, for the treatmentRead More

Medac GmbH Supports Guideline on Intravesical Instillations of BCG/MMC

Uncategorized January 20, 2015 at 3:10 PM 0 comments

Hamburg / Wedel (20 January 2015). medac GmbH has provided the European Association of Urology Nurses (EAUN) with an unrestricted educational grant to support the creation of a booklet “Guideline on intravesical instillations of BCG/MMC”.  Over the past 30 years medac has provided urologists with their expertise and products forRead More

THSD7A: Another Hope for Membranous Nephropathy Sufferers

THSD7A: Another Hope for Membranous Nephropathy Sufferers

Nephrology January 19, 2015 at 10:08 AM 0 comments

IDENTIFICATION of a protein, thrombospondin type-1 domain-containing protein 7A (THSD7A), that turns a person’s immune system against itself in sufferers of membranous nephropathy (MN) could give patients a fighting chance now that a blood test can be developed to diagnose and monitor this prevalent type of kidney disease. MN isRead More